tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

CRISPR Therapeutics AG

CRSP
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
47.640USD
+0.090+0.19%
์ข…๊ฐ€ย 07-29 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
4.59B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

CRISPR Therapeutics AG

47.640
+0.090+0.19%
๊ฐœ์š”
๊ธˆ์œต
ํ† ๋ก 
๋ถ„์„
ํšŒ์‚ฌ
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

๊ฐœ์š”

๊ธˆ์œต

ํ† ๋ก 

๋ถ„์„

ํšŒ์‚ฌ

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

CRSP ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด CRISPR Therapeutics AG์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

CRISPR Therapeutics AG ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 4, 2026
EPS / ์˜ˆ์ƒ
-1.28/-1.22
์ˆ˜์ต / ์˜ˆ์ƒ
1.46M/14.72M
์˜ˆ์ •๋œ ์‹ค์  ๋ฐœํ‘œ ์ผ์ • ๋ณด๊ธฐ >>
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
3.51M
-90.59%
EPS(YoY)
-6.47
-48.97%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/29
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
19.12%-1.28
-213.87%-1.37
-15.62%-1.17
-60.91%-2.40
-11.02%-1.58
-138.94%-0.44
28.60%-1.01
-51.44%-1.49
-111.34%-1.43
179.51%1.12
---1.41
---0.98
---0.67
---1.41
---6.96
----
----
----
----
----
์ˆ˜์ต
68.55%1.46M
-97.58%864.00K
47.67%889.00K
72.53%892.00K
71.63%865.00K
-82.26%35.69M
--602.00K
-99.26%517.00K
-99.50%504.00K
3353333.33%201.21M
-100.00%0.00
44203.80%70.00M
10538.30%100.00M
-99.95%6.00K
-88.59%94.00K
-99.98%158.00K
74.40%940.00K
3386.22%12.90M
456.76%824.00K
2046947.73%900.70M
์ˆœ์ด์ต
9.61%-122.93M
-250.07%-130.61M
-23.85%-106.44M
-64.98%-208.55M
-16.64%-136.00M
-141.76%-37.31M
23.37%-85.94M
-62.60%-126.41M
-119.71%-116.59M
180.80%89.35M
35.75%-112.15M
58.17%-77.74M
70.39%-53.06M
21.72%-110.58M
-37.27%-174.55M
-124.48%-185.83M
-58.37%-179.22M
-31.96%-141.25M
-37.55%-127.15M
1053.13%759.23M
์ˆœ์ด์ต๋ฅ 
46.37%-8431.48%
-14360.87%-15117.25%
16.13%-11973.12%
4.38%-23379.93%
32.04%-15722.08%
-335.42%-104.54%
---14276.08%
-21915.96%-24450.29%
-43493.96%-23133.13%
100.00%44.41%
----
---111.06%
---53.06%
---1842916.67%
---45268.46%
----
----
----
----
----
์ด ์ด์ต๋ฅ 
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
----
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
--21.48%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
68.55%1.46M
-97.58%864.00K
47.67%889.00K
72.53%892.00K
71.63%865.00K
-82.26%35.69M
--602.00K
-99.26%517.00K
-99.50%504.00K
3353333.33%201.21M
-100.00%0.00
44203.80%70.00M
10538.30%100.00M
-99.95%6.00K
-88.59%94.00K
-99.98%158.00K
74.40%940.00K
3386.22%12.90M
456.76%824.00K
2046947.73%900.70M
์˜์—… ์ด์ต
12.25%-130.25M
-139.62%-154.76M
-19.91%-132.06M
12.02%-133.07M
-5.57%-148.42M
-192.82%-64.59M
16.83%-110.13M
-58.85%-151.26M
-118.01%-140.59M
152.90%69.58M
27.40%-132.41M
48.04%-95.22M
63.35%-64.49M
9.72%-131.54M
-41.55%-182.39M
-124.03%-183.26M
-53.63%-175.97M
-35.20%-145.70M
-39.45%-128.85M
1045.13%762.62M
์ˆœ์ด์ต
9.61%-122.93M
-250.07%-130.61M
-23.85%-106.44M
-64.98%-208.55M
-16.64%-136.00M
-141.76%-37.31M
23.37%-85.94M
-62.60%-126.41M
-119.71%-116.59M
180.80%89.35M
35.75%-112.15M
58.17%-77.74M
70.39%-53.06M
21.72%-110.58M
-37.27%-174.55M
-124.48%-185.83M
-58.37%-179.22M
-31.96%-141.25M
-37.55%-127.15M
1053.13%759.23M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
31.10%2.45B
2.51%1.99B
-0.76%1.93B
-13.77%1.73B
-11.89%1.87B
1.52%1.94B
10.41%1.94B
8.11%2.01B
11.09%2.12B
2.97%1.91B
-8.91%1.76B
-11.75%1.86B
-15.60%1.91B
-23.35%1.85B
-23.27%1.93B
-19.61%2.11B
23.37%2.26B
40.83%2.42B
81.10%2.52B
171.43%2.62B
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
14.10%136.29M
69.88%149.12M
32.45%118.96M
-18.35%104.36M
0.38%119.45M
-19.31%87.78M
-19.26%89.81M
-3.77%127.82M
-18.94%118.99M
-10.17%108.79M
-26.27%111.23M
10.74%132.84M
29.11%146.79M
1.02%121.11M
56.82%150.87M
20.05%119.96M
36.84%113.70M
27.18%119.88M
14.33%96.21M
34.12%99.92M
์ด ์ž์‚ฐ
25.84%2.73B
1.04%2.27B
-0.48%2.25B
-13.25%2.03B
-11.19%2.17B
0.56%2.24B
8.11%2.26B
6.50%2.34B
8.67%2.44B
-0.60%2.23B
-11.33%2.09B
-10.81%2.20B
-13.88%2.24B
-18.49%2.24B
-16.60%2.35B
-15.04%2.46B
33.11%2.61B
50.54%2.75B
90.01%2.82B
177.06%2.90B
๋ถ€์ฑ„ ์ด๊ณ„
170.45%911.26M
10.80%343.43M
4.06%329.33M
-11.23%318.59M
-5.11%336.94M
-10.62%309.95M
-11.86%316.47M
-5.80%358.90M
-8.83%355.08M
-5.66%346.77M
-10.11%359.04M
2.27%380.99M
7.81%389.47M
4.30%367.58M
29.34%399.40M
25.97%372.53M
137.03%361.26M
115.24%352.42M
117.90%308.80M
117.66%295.72M
์ž๋ณธ ์ด๊ณ„
-0.80%1.81B
-0.53%1.92B
-1.22%1.92B
-13.62%1.71B
-12.23%1.83B
2.62%1.93B
12.26%1.94B
9.08%1.98B
12.35%2.08B
0.39%1.88B
-11.57%1.73B
-13.14%1.82B
-17.37%1.85B
-21.84%1.88B
-22.24%1.95B
-19.70%2.09B
24.34%2.24B
44.18%2.40B
87.07%2.51B
185.92%2.60B
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-101.86%-108.90M
-84.99%-92.55M
20.84%-84.63M
-19.14%-113.88M
-149.15%-53.95M
47.92%-50.03M
-168.25%-106.91M
28.27%-95.58M
1147.32%109.75M
15.23%-96.07M
62.12%-39.86M
6.14%-133.25M
106.51%8.80M
-31.72%-113.33M
-29.37%-105.22M
-117.59%-141.96M
-34.35%-135.24M
-5.94%-86.04M
-7.44%-81.33M
2856.25%807.00M
์ˆœํˆฌ์ž
-1979.19%-410.74M
-64.85%37.20M
26.22%-119.23M
155.14%69.98M
79.80%-19.75M
229.93%105.83M
-233.17%-161.60M
-158.50%-126.91M
-183.00%-97.80M
53.60%-81.45M
38.74%121.35M
486.87%216.92M
202.89%117.83M
-1913.91%-175.53M
115.48%87.46M
80.90%-56.07M
31.79%-114.52M
95.73%-8.72M
-71.10%-565.18M
-8045.24%-293.64M
์ˆœ์žฌ๋ฌดํ™œ๋™
5490.37%591.91M
589.82%116.41M
2978.49%296.77M
584.55%2.26M
-96.54%10.59M
-56.66%16.88M
519.54%9.64M
-102.78%-466.00K
5561.25%305.93M
1471.39%38.94M
-89.70%1.56M
61.93%16.77M
-49.25%5.40M
-60.66%2.48M
47.98%15.11M
22.62%10.35M
-95.29%10.65M
-98.47%6.30M
-98.01%10.21M
-90.57%8.44M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

CRISPR Therapeutics AG์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 3.51M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 37.31M์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 1.99B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.51์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CRISPR Therapeutics AG์˜ ์ด์ž์‚ฐ์€ 2.27B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1.04์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CRISPR Therapeutics AG์˜ ์ด๋ถ€์ฑ„๋Š” 343.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 10.80์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CRISPR Therapeutics AG์˜ ์ด์ž๋ณธ์€ 1.92B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -0.53์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CRISPR Therapeutics AG์˜ ์ˆœ์˜์—…์†Œ๋“์€ -568.32M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -21.81์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CRISPR Therapeutics AG์˜ ์ˆœํˆฌ์ž๋Š” -31.80M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 88.66์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, CRISPR Therapeutics AG์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 426.03M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 28.33์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -6.47์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -48.97์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -581.60M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -58.80์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -16569.77์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -1588.14์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -30.18์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -57.19์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -25.81์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -57.54์ž…๋‹ˆ๋‹ค.

CRISPR Therapeutics AG์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
CRISPR Therapeutics AG์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -568.32M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -21.81์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ